VIGIL NEUROSCIENCE, INC.

(VIGL)
  Report
Delayed Nasdaq  -  04:00 2022-08-12 pm EDT
7.920 USD   +8.34%
08/12VIGIL NEUROSCIENCE : Announces $75 Million Private Placement Financing - Form 8-K
PU
08/12VIGIL NEUROSCIENCE, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Other Events, Financial Statements and Exhibits (form 8-K)
AQ
08/12Vigil Neuroscience Enters $75 Million Private Investment in Public Equity Financing
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Certain Stock Options of Vigil Neuroscience, Inc. are subject to a Lock-Up Agreement Ending on 6-JUL-2022.

07/06/2022 EDT

Certain Stock Options of Vigil Neuroscience, Inc. are subject to a Lock-Up Agreement Ending on 6-JUL-2022. These Stock Options will be under lockup for 180 days starting from 7-JAN-2022 to 6-JUL-2022. Details: The company's directors and executive officers, and the holders of substantially all of capital stock and securities convertible into or exchangeable for capital stock have entered into lock-up agreements with the underwriters and/or are subject to market standoff agreements or other agreements with the company, which prevents them from selling any of common stock or any securities convertible into or exercisable or exchangeable for common stock for a period of not less than 180 days from the date of this prospectus without the prior written consent of the representatives, subject to certain exceptions.


© S&P Capital IQ 2022
All news about VIGIL NEUROSCIENCE, INC.
08/12VIGIL NEUROSCIENCE : Announces $75 Million Private Placement Financing - Form 8-K
PU
08/12VIGIL NEUROSCIENCE, INC. : Entry into a Material Definitive Agreement, Unregistered Sale o..
AQ
08/12Vigil Neuroscience Enters $75 Million Private Investment in Public Equity Financing
MT
08/12Vigil Neuroscience Announces $75 Million Private Placement Financing
GL
08/12Vigil Neuroscience, Inc. announced that it expects to receive $74.999705 million in fun..
CI
08/08VIGIL NEUROSCIENCE : Reports Second Quarter 2022 Financial Results and Provides Business U..
PU
08/08VIGIL NEUROSCIENCE, INC. Management's Discussion and Analysis of Financial Condition a..
AQ
08/08Vigil Neuroscience Reports Second Quarter 2022 Financial Results and Provides Business ..
GL
08/08Vigil Neuroscience Reports Second Quarter 2022 Financial Results and Provides Business ..
GL
08/08Vigil Neuroscience, Inc. Reports Earnings Results for the Second Quarter and Six Months..
CI
More news
Analyst Recommendations on VIGIL NEUROSCIENCE, INC.
More recommendations
Financials (USD)
Sales 2022 - - -
Net income 2022 -74,6 M - -
Net cash 2022 105 M - -
P/E ratio 2022 -2,97x
Yield 2022 -
Capitalization 224 M 224 M -
EV / Sales 2022 -
EV / Sales 2023 -
Nbr of Employees 48
Free-Float 87,2%
Chart VIGIL NEUROSCIENCE, INC.
Duration : Period :
Vigil Neuroscience, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends VIGIL NEUROSCIENCE, INC.
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 7,92 $
Average target price 19,25 $
Spread / Average Target 143%
EPS Revisions
Managers and Directors
Ivana Magovcevic-Liebisch President, Chief Executive Officer & Director
Jennifer Ziolkowski Chief Financial Officer
Bruce Lee Booth Chairman
Spyridon Papapetropoulos Chief Medical Officer
Gerhard Koenig Independent Director
Sector and Competitors
1st jan.Capi. (M$)
VIGIL NEUROSCIENCE, INC.0.00%224
MODERNA, INC.-32.60%66 966
IQVIA HOLDINGS INC.-12.88%45 846
LONZA GROUP AG-25.13%44 851
SEAGEN INC.10.05%31 380
ALNYLAM PHARMACEUTICALS, INC.37.90%28 068